UK biotech Compass Pathways is planning a $100 million US IPO as it seeks to further develop its depression treatment based on psilocybin – an active ingredient that can be found in magic mushrooms.

Compass Mental Health & Wellness (MHW) invites you to partner with us. At Compass MHW, you are not just another patient, you are part of a team. We believe in a holistic approach to mental health ...